Nicox S.A.

€0.28As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALCOXHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (27.68%)
Div yield —
ROE 365.60%
Biotechnology
Beta (5Y) 0.50
PE TTM 4.176
TSR TTM (17.27%)
Mkt cap €25.12M
ROIC 64.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.358
25.75%
(50.34%)
Hold 5|3|12|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
26.21%
17.11%
6.56%
(0.39%)
Revenue€M
1.379
1.424
1.382
1.369
—
0.62%
(3.21%)
(3.10%)
Peers (US$28.20M)
Cap (US$)
PE
40.99M
—
23.06M
—
28.28M
—
Capital
TTM
5Y
10Y
Leveragex
1.288
(0.169)
(0.153)
EBIT/Intx
1.097
1.629
1.264
Own earn%
(288.94)
131.65
130.01
Sh yield%
35.84
41.19
40.23
Owners
Insiders/Inst%
5.50
51.03
Short interest%
3.35
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
18–26
$1 testx
—
Incr. ROIC%
40